Iron sucrose
As of the edition of 20 October 2026, Iron sucrose is a small molecule: marketed, first approved in 2000 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2000
- Kind
- Small molecule
- Brand name
- Venofer
- First approved
- 6 November 2000 (US)
- Approvals on record
- 5 in 1 region
- Holder of the most recent approval
- American Regent
- Registered trials
- 46, 11 stopped early
- Disease areas
- Blood and lymph; Nutrition and metabolism; Pregnancy and women's health; Urinary and reproductive; Heart and blood vessels; Cancer
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 13 | 7 | 1 | 1 |
| Phase 1 | 6 | 5 | 0 | 1 |
| Phase 2 | 9 | 2 | 0 | 7 |
| Phase 3 | 7 | 4 | 0 | 1 |
| Phase 4 | 11 | 6 | 0 | 1 |
| All trials | 46 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| American Regent | Acquired holder and Lead sponsor of trials | 2019 to now |